Estrogen-related receptor α participates transforming growth factor-β (TGF-β) induced epithelial-mesenchymal transition of osteosarcoma cells

References

• Ao A, Wang H, Kamarajugadda S, Lu J. Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors. Proc Natl Acad Sci 2008; 105:7821-6; PMID:18509053; https://doi.org/10.1073/pnas.0711677105
   PubMed Web of Science ®Google Scholar
• Band AM, Laiho M. Crosstalk of TGF-β and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 2011; 16:109-15; PMID:21390570; https://doi.org/10.1007/s10911-011-9203-7
   PubMed Web of Science ®Google Scholar
• Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J, De Herreros AG. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Na Cell Biol 2000; 2:84-9; https://doi.org/10.1038/35000034
   PubMed Web of Science ®Google Scholar
• Bonnelye E, Merdad L, Kung V, Aubin JE. The orphan nuclear estrogen receptor-related receptor α (ERRalpha) is expressed throughout osteoblast differentiation and regulates bone formation in vitro. J Cell Biol 2001; 153:971-84; PMID:11381083; https://doi.org/10.1083/jcb.153.5.971
   PubMed Web of Science ®Google Scholar
• Cano A, Peinado H, Olmeda D. Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7:415-28; PMID:17508028; https://doi.org/10.1038/nrc2131
   PubMed Web of Science ®Google Scholar
• Chen P, Wang HB, Duan ZJ, Zou JX, Chen HW, He W, Wang JJ. Estrogen-related receptor α confers Methotrexate resistance via attenuation of reactive oxygen species production and p53 apoptosis pathway in osteosarcoma U2OS cells. J Bone Miner Res 2014; 29:S142-S; https://doi.org/10.1002/jbmr.2012
   PubMed Web of Science ®Google Scholar
• Chen ZJ, Yang XL, Liu H, Wei W, Zhang KS, Huang HB, Giesy JP, Liu HL, Du J, et al. Bisphenol A modulates colorectal cancer protein profile and promotes the metastasis via induction of epithelial to mesenchymal transitions. Arch Toxicol 2015; 89:1371-81; PMID:25119493; https://doi.org/10.1007/s00204-014-1301-z
   PubMed Web of Science ®Google Scholar
• Daw NC, Chou AJ, Jaffe N, Rao BN, Billups CA, Rodriguez-Galindo C, Meyers PA, Huh WW. Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review. Br J Cancer 2015; 112:278-82; PMID:25422914; https://doi.org/10.1038/bjc.2014.585
   PubMed Web of Science ®Google Scholar
• Dufour CR, Wilson BJ, Huss JM, Kelly DP, Alaynick WA, Downes M, Evans RM, Blanchette M, Giguere V. Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. Cell Metab 2007; 5:345-56; PMID:17488637; https://doi.org/10.1016/j.cmet.2007.03.007
   PubMed Web of Science ®Google Scholar
• Fradet A, Sorel H, Bouazza L, Goehrig D, Depalle B, Bellahcene A, Castronovo V, Follet H, Descotes F, Aubin JE, et al. Dual function of ERRalpha in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. Cancer Res 2011; 71:5728-38; PMID:21734015; https://doi.org/10.1158/0008-5472.CAN-11-1431
   PubMed Web of Science ®Google Scholar
• Grignani G, Palmerini E, Ferraresi V, D'Ambrosio L, Bertulli R, Asaftei SD, Tamburini A, Pignochino Y, Sangiolo D, Marchesi E, et al. Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial. Lancet Oncol 2015; 16:98-107; PMID:25498219; https://doi.org/10.1016/S1470-2045(14)71136-2
   PubMed Web of Science ®Google Scholar
• Hou CH, Lin FL, Tong KB, Hou SM, Liu JF. Transforming growth factor α promotes osteosarcoma metastasis by ICAM-1 and PI3K/Akt signaling pathway. Biochem Pharmacol 2014; 89:453-63; PMID:24685520; https://doi.org/10.1016/j.bcp.2014.03.010
   PubMed Web of Science ®Google Scholar
• Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nat Med 1996; 2:1132-6; PMID:8837613; https://doi.org/10.1038/nm1096-1132
   PubMed Web of Science ®Google Scholar
• Katsuno Y, Lamouille S, Derynck R. TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol 2012; 25:76-84; https://doi.org/10.1097/CCO.0b013e32835b6371
   Web of Science ®Google Scholar
• Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 2009; 15:195-206; PMID:19249678; https://doi.org/10.1016/j.ccr.2009.01.023
   PubMed Web of Science ®Google Scholar
• Lam SS, Mak AS, Yam JW, Cheung AN, Ngan HY, Wong AS. Targeting estrogen-related receptor α inhibits epithelial-to-mesenchymal transition and stem cell properties of ovarian cancer cells. Mol Ther 2014; 22:743-51; PMID:24419103; https://doi.org/10.1038/mt.2014.1
   PubMed Web of Science ®Google Scholar
• Li H, Wang H, Wang F, Gu Q, Xu X. Snail involves in the transforming growth factor beta1-mediated epithelial-mesenchymal transition of retinal pigment epithelial cells. Plos One 2011; 6:e23322; https://doi.org/10.1371/journal.pone.0023322
   PubMed Web of Science ®Google Scholar
• Luo J, Sladek R, Carrier J, Bader JA, Richard D, Giguere V. Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor α. Mol Cell Biol 2003; 23:7947-56; PMID:14585956; https://doi.org/10.1128/MCB.23.22.7947-7956.2003
   PubMed Web of Science ®Google Scholar
• Matsuyama S, Iwadate M, Kondo M, Saitoh M, Hanyu A, Shimizu K, Aburatani H, Mishima HK, Imamura T, Miyazono K, et al. SB-431542 and Gleevec inhibit transforming growth factor-β-induced proliferation of human osteosarcoma cells. Cancer Res 2003; 63:7791-8; PMID:14633705
   PubMed Web of Science ®Google Scholar
• Morrison CD, Parvani JG, Schiemann WP. The relevance of the TGF-β Paradox to EMT-MET programs. Cancer Lett 2013; 341:30-40; PMID:23474494; https://doi.org/10.1016/j.canlet.2013.02.048
   PubMed Web of Science ®Google Scholar
• Raymond AK, Jaffe N. Osteosarcoma Multidisciplinary Approach to the Management from the Pathologist's Perspective. Pediatric and Adolescent Osteosarcoma 2009; 152:63-84; https://doi.org/10.1007/978-1-4419-0284-9_4
   Google Scholar
• Saitoh M. Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor- signaling during tumor progression. Cancer Sci 2015; 106:481-8; PMID:25664423; https://doi.org/10.1111/cas.12630
   PubMed Web of Science ®Google Scholar
• Schedlich LJ, Yenson VM, Baxter RC. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells. Mol Cell Endocrinol 2013; 377:56-64; PMID:23831640; https://doi.org/10.1016/j.mce.2013.06.033
   PubMed Web of Science ®Google Scholar
• Stein RA, Gaillard S, McDonnell DP. Estrogen-related receptor α induces the expression of vascular endothelial growth factor in breast cancer cells. J Steroid Biochem Mol Biol 2009; 114:106-12; PMID:19429439; https://doi.org/10.1016/j.jsbmb.2009.02.010
   PubMed Web of Science ®Google Scholar
• Sung JY, Park SY, Kim JH, Kang HG, Yoon JH, Na YS, Kim YN, Park BK. Interferon consensus sequence-binding protein (ICSBP) promotes epithelial-to-mesenchymal transition (EMT)-like phenomena, cell-motility, and invasion via TGF-β signaling in U2OS cells. Cell Death Dis 2014; 5:e1224; https://doi.org/10.1038/cddis.2014.189
   PubMed Web of Science ®Google Scholar
• Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2:442-54; https://doi.org/10.1038/nrc822
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139:871-90; PMID:19945376; https://doi.org/10.1016/j.cell.2009.11.007
   PubMed Web of Science ®Google Scholar
• Wang LN, Wang Y, Lu Y, Yin ZF, Zhang YH, Aslanidi GV, Srivastava A, Ling CQ, Ling C. Pristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo. J Integr Med 2014; 12:20-34; PMID:24461592; https://doi.org/10.1016/S2095-4964(14)60003-0
   PubMedGoogle Scholar
• Wu YM, Chen ZJ, Liu H, Wei WD, Lu LL, Yang XL, Liang WT, Liu T, Liu HL, Du J, et al. Inhibition of ERRalpha suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin. Oncotarget 2015; 6(28):25588-601; https://doi.org/10.18632/oncotarget.4436
   PubMed Web of Science ®Google Scholar
• Xu J, Lamouille S, Derynck R. TGF-β-induced epithelial to mesenchymal transition. Cell Res 2009; 19:156-72; PMID:19153598; https://doi.org/10.1038/cr.2009.5
   PubMed Web of Science ®Google Scholar
• Yang G, Yuan J, Li K. EMT transcription factors: implication in osteosarcoma. Med Oncol 2013; 30:697; PMID:23975634; https://doi.org/10.1007/s12032-013-0697-2
   PubMed Web of Science ®Google Scholar
• Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117:927-39; PMID:15210113; https://doi.org/10.1016/j.cell.2004.06.006
   PubMed Web of Science ®Google Scholar
• Yang JL, Zhang W. New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol 2013; 25:398-406; PMID:23666471; https://doi.org/10.1097/CCO.0b013e3283622c1b
   PubMed Web of Science ®Google Scholar